In this podcast we speak with Dr Hakim-Moulay Dehbi, who is currently Head of Statistics at the Comprehensive Clinical Trials Unit at UCL, about his last paper on controlled backfill in oncology dose-finding trials. He tells us about the motivation for this work, and more importantly how the interests of patients with cancer need to be taken into account in dose-finding designs. 

For more information and to access the transcript: www.ucl.ac.uk/statistics/

Date of episode recording: 2022-04-2
Duration: 
Language of episode: English
Presenter: Nathan Green
Guests: Hakim-Moulay Dehbi
Producer: Nathan Green

INTERACTIVE TECHNOLOGIES IN MUSEUMS - A Conversation with Rozhen Mohammed

UCL (University College London) is consistently ranked among the world's top ten universities (QS World University Rankings 2010 - 2021). Our excellence extends across all academic disciplines, from one of the world's foremost centres for research and teaching in the biological sciences to world-renowned centres for architecture (UCL Bartlett), education (UCL IOE) and fine art (UCL Slade School).

UCL is London's leading multidisciplinary university, with more than 13,000 staff and 43,000 students from 150 different countries. Founded in 1826 in the heart of London, UCL was the first university in England to welcome students of any religion and the first to welcome women on equal terms with men.

UCL Minds brings together UCL’s knowledge, insights, and ideas through events, activities, and digital content open to everyone. Find out what’s on UCL Minds: www.ucl.ac.uk/minds